This article was first published 22 years ago

Ranbaxy gets USFDA nod for generic Serzone

Share:

April 28, 2003 14:29 IST

The United States Food and Drugs Administration has granted Ranbaxy Laboratories a tentative approval to market a generic form of Bristol-Myers' anti-depressant
v_1">
Serzone, US FDA's web site said.
Share:

WEB STORIES

VIDEOS

Moneywiz Live!